Clinical Trials Directory

Trials / Completed

CompletedNCT04741152

Blinded Resection in Case of the Pancreatic Insulinoma

Blinded Resection Avoided in Case of the Pancreatic Insulinoma

Status
Completed
Phase
Study type
Observational
Enrollment
197 (actual)
Sponsor
Vishnevsky Center of Surgery · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The blinded resection avoided in case of pancreatic insulinoma

Detailed description

Despite of the technique and technology developement there are still a lot of troubles to verify small benign-looking pancreatic NETs. It can be especially important in case of insulinoma. The organic hyperilsulinism and severe hypoglicemia causeb by the insulin/proinsulin - producing lesion can lead to severe complications and evem death. There are some cases of the blinded resections of the pancreas in patients with the "hidden" insulinoma when the tumor can't be revealed during the preoperative diagnostics and intraoperatively. Unfortunately, blind resection do not solve the problem of the hypoglicemia but also cause the specific pancreatic complications.

Conditions

Interventions

TypeNameDescription
PROCEDUREPancreatic resectionDifferent pancreatic resections

Timeline

Start date
2010-01-01
Primary completion
2020-06-01
Completion
2020-12-01
First posted
2021-02-05
Last updated
2021-02-05

Source: ClinicalTrials.gov record NCT04741152. Inclusion in this directory is not an endorsement.